MarketTwits
267K subscribers
78.9K photos
2.99K videos
1.1K files
83.6K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

№ 4943378258
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#THOR +167% Synthorx, Inc. -company announced it would be acquired by Sanofi for $68 per share in cash.

#XBIT +149% XBiotech Inc. - the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.

#ARQL +102% ArQule, Inc. - the company agreed to be acquired by Merck & Co., Inc. #MRK for $20 per share in cash.

#OBSV +51% ObsEva SA - after reporting positive results from uterine fibroids Phase 3 study (PRIMROSE 2) of linzagolix.

#FATE +26% Fate Therapeutics, Inc. - the company disclosed that combination of FT596 with rituximab showed durable tumor clearance in vivo in preclinical lymphoma model at the ASH 2019.

#TGTX +24% TG Therapeutics, Inc. - the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.

#PCG +21% PG&E Corporation - the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.

#KRMD +12% Repro Med Systems, Inc.

#RRTS +11% Roadrunner Transportation Systems, Inc. - reported the sale of its Flatbed Business unit for $30 million in cash.

#SMLP +11% Summit Midstream Partners, LP

#FNV +8% Franco-Nevada Corporation

#BLUE +6% bluebird bio, Inc. - presented new data from ongoing Phase 1/2 HGB-206 study of LentiGlobin gene therapy for sickle cell disease at the ASH 2019.

#LPL +6% LG Display Co., Ltd.

ВНИЗ

#DPLO -32% Diplomat Pharmacy, Inc. -UnitedHealth Group Inc
#UNH announced plans to buy Diplomat Pharmacy for around $300 million.

#KALV -30% KalVista Pharmaceuticals, Inc. - the company disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.

#DDOG -4% Datadog, Inc.

#KOS -4% Kosmos Energy Ltd

#DRIO -4% DarioHealth Corp.

#TGT -3% Target Corporation

#RDHL -3% RedHill Biopharma Ltd.
🇺🇸 #premarket #сша
премаркет США - акции - upgrad-ы и downgrad-ы:

UPGRADE
#NEWR New Relic -Raymond James
#MNST Monster Beverage -Morgan Stanley
#CE Celanese -B of A Securities
#HES Hess -Piper Sandler
#ADNT Adient -Buckingham
#OFC Corporate Office Props -Capital One
#CHTR Charter Communications -Credit Suisse
#BLUE bluebird bio -Evercore ISI Group
#CL Colgate-Palmolive -Atlantic Equities
#CL Colgate-Palmolive -RBC Capital
#NKE Nike -UBS
#XLRN Acceleron Pharma -Morgan Stanley
#MMSI Merit Medical Systems -Raymond James
#ULTA Ulta Beauty -Goldman Sachs
#NKTR Nektar Therapeutics -Mizuho
#REMYY Rémy Cointreau -Bernstein
#KKR KKR & Co -Barclays
#MUSA Murphy USA -JP Morgan
#WHF WhiteHorse Finance -JP Morgan
#SLRC Solar Capital -JP Morgan
#OUT Outfront Media -JP Morgan
#CVI CVR Energy -Goldman Sachs
#AXTA Axalta Coating Systems -BMO Capital
#VRTS Virtus Investment -Barclays
#CLNE Clean Energy Fuels -Raymond James
#STX Seagate Technology -Stifel Nicolaus
#SMED Sharps Compliance -Stifel Nicolaus

DOWNGRADE
#EA Electronic Arts - BMO Capital
#XOM Exxon Mobil -Goldman Sachs
#VZ Verizon Communications -Credit Suisse
#VIAC ViacomCBS -Credit Suisse
#CRSP CRISPR Therapeutics -Evercore ISI Group
#NOC Northrop Grumman -Goldman Sachs
#DERM Dermira -Guggenheim
#BUSE First Busey -DA Davidson
#FLMN Falcon Minerals -Credit Suisse
#LAIX LAIX -Goldman Sachs
❗️🇺🇸#BLUE #spo
Bluebird bio - SPO на $400 млн
🇺🇸#BLUE
Bluebird - допэмиссия на 9 090 910 акций по $55
🇺🇸#BMY #BLUE
Bristol-Myers, bluebird bio get FDA priority review for Ide-cel
⚠️🇺🇸#BLUE Bluebird Bio downgraded to Market Perform from Outperform at BMO Capital
❗️🇺🇸#BLUE
Bluebird Bio в 2021 году проведет spinoff портфеля лекарств от рака, чтобы сосредоточиться на редких генетических заболеваниях после разделения
🇺🇸#фарма #акции #сша
BofA про биофарму США

#HZNP #EXEL #BLUE #CHRS #JAZZ #MRTX #CARA
💥🇺🇸#BLUE
bluebird bio Receives EC Approval for SKYSONA (elivaldogene autotemcel, Lenti-D) Gene Therapy for Patients Less Than 18 Years of Age With Early Cerebral Adrenoleukodystrophy (CALD) Without Matched Sibling Donor
🇺🇸#BLUE
Nasdaq приостановил торги акциями Bluebird bio на 9-10 июня в преддверии заседания FDA, на котором будут обсуждаться заявки компании на одобрение ее генной терапии